삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

산부인과 이정원 교수

진료분야
자궁경부암, 난소암, 자궁내막암
진료일정 05 月
날짜
목
01
금
02
토
03
일
04
월
05
화
06
수
07
목
08
금
09
토
10
일
11
월
12
화
13
수
14
목
15
금
16
토
17
일
18
월
19
화
20
수
21
목
22
금
23
토
24
일
25
월
26
화
27
수
28
목
29
금
30
토
31
오전
오후
진료일정 06 月
날짜
일
01
월
02
화
03
수
04
목
05
금
06
토
07
일
08
월
09
화
10
수
11
목
12
금
13
토
14
일
15
월
16
화
17
수
18
목
19
금
20
토
21
일
22
월
23
화
24
수
25
목
26
금
27
토
28
일
29
월
30
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
2010.08 고려대학교 대학원 산부인과학 박사
2005.02 성균관대학교 대학원 의학과 석사
1995.02 경상대학교 의과대학 의학사
1991.02 경상대학교 자연과학대 의예과

경력

경력
2019.04 ~현재 성균관대학교 의과대학 산부인과학교실 교수
2016.12 ~현재 삼성서울병원 암병원 부인암센터장
2005.03 ~현재 삼성서울병원 산부인과 전문의
2003.04 ~현재 삼성서울병원 암병원 부인암센터 교수
2021.04 ~ 2023.03 성균관대학교 의과대학 산부인과학교실 주임교수 및 삼성서울병원 산부인과장
2013.03 ~ 2019.03 성균관대학교 의과대학 산부인과학교실 부교수
2009.03 ~ 2013.03 성균관대학교 의과대학 산부인과학교실 조교수
2005.03 ~ 2009.02 삼성서울병원 산부인과 임상조교수
2007.06 ~ 2008.11 미국 MD Anderson 암센터 방문 조교수
2003.04 ~ 2005.02 삼성서울병원 산부인과 부인종양 전임의
2000.05 ~ 2003.04 공중보건의 근무
2000.03 산부인과 전문의 자격 취득
1996.02 ~ 2000.02 삼성서울병원 산부인과 레지던트 과정 수료
1995.03 ~ 1996.02 삼성서울병원 인턴과정 수료

학회활동

학회활동
2017.03 ~ 현재 대한부인종양학회 상임이사
2017.03 ~ 현재 대한산부인과내시경학회 상임이사
2015.01 ~ 2017.09 (재) 건강한여성재단 사무총장
2016.03 ~ 2016.10 대한부인종양학회 사무총장

수상이력

수상이력
2014.04 Tokyo International Forum, Japan Patient-derived Tumor Xenograft Model for Gynecologic Cancer 구연상
2010.10 Interaction with microRNA-200c and BRD7 in endometrial carcinoma 대한산부인과학회 최우수구연상
논문
  • ANTICANCER RES 2024 10.21873/anticanres.17257 Anticancer Effects of BAF312 (Siponimod) in Epithelial Ovarian Cancer Ha, H; Ryu, JY; Yoon, S; Cho, YJ; Choi, JJ; Hwang, JR; Choi, JY; Han, HD; Lee, JW
    View PubMed
  • CANCERS 2024 10.3390/cancers16193422 From the Beginning of the Korean Gynecologic Oncology Group to the Present and Next Steps Min, KJ; Kim, NK; Song, JY; Choi, MC; Lee, SW; Lee, KH; Kim, MK; Kang, SK; Choi, CH; Lee, JW; Lee, EJ; Eom, KY; Kim, SW; Cho, HBY; Lee, SJ; Lim, MC; Bae, J; Yoo, CW; Kim, K; Kim, DY; Lee, CL; Ryu, SY; Jeon, S; Kim, JW; Nam, BH; Kang, SB; Kim, KT; Nam, JH; Kim, BG; Kim, YM; Kim, JH
    View PubMed
  • INT J GYNECOL PATHOL 2024 10.1097/PGP.0000000000001007 Risk Factors Affecting Clinical Outcomes of Low-risk Early-stage Human Papillomavirus-Associated Endocervical Adenocarcinoma Treated by Surgery Alone: Application of Silva Pattern Bae, BK; Bae, H; Cho, WK; Kim, BG; Choi, CH; Kim, TJ; Lee, YY; Lee, JW; Kim, HS; Park, W
    View PubMed
  • INT J NANOMED 2024 10.2147/IJN.S468935 Evaluation of Anticancer Efficacy of D-α-Tocopheryl Polyethylene-Glycol Succinate and Soluplus® Mixed Micelles Loaded with Olaparib and Rapamycin Against Ovarian Cancer Shin, YB; Choi, JY; Yoon, MS; Yoo, MK; Shin, DH; Lee, JW
    View PubMed
  • GYNECOL ONCOL 2024 10.1016/j.ygyno.2024.06.011 Anti-cancer effects of benzimidazole derivative BNZ-111 on paclitaxel-resistant ovarian cancer Koh, B; Ryu, JY; Noh, JJ; Hwang, JR; Choi, JJ; Cho, YJ; Jang, J; Jo, JH; Lee, K; Lee, JW
    View PubMed
  • J GYNECOL ONCOL 2024 10.3802/jgo.2024.35.e87 Current treatment strategies for ovarian cancer in the East Asian Gynecologic Oncology Trial Group (EAGOT) Kobayashi, Y; Shimada, M; Tamate, M; Cho, HW; Zhu, J; Chou, HH; Kajiyama, H; Okamoto, A; Aoki, D; Kang, S; Lee, JW; Kim, JW; Kim, JH; Lin, ZQ; Liu, JH; Wu, XH; Lai, HC; Chang, TC; Lai, CH; Kim, YM; Enomoto, T
    View PubMed
  • FRONT IMMUNOL 2024 10.3389/fimmu.2024.1371353 Efficacy and safety of BVAC-C in HPV type 16-or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study Choi, CH; Lee, JW; Bae, DS; Kang, ES; Cho, DC; Kim, YM; Kim, K; Kim, JW; Kim, HS; Kim, YT; Lee, JY; Lim, MC; Oh, T; Song, B; Jeon, I; Park, M; Kim, WH; Kang, CY; Kim, BG
    View PubMed
  • FRONT GENET 2024 10.3389/fgene.2024.1342021 Comparison of RNA-Seq and microarray in the prediction of protein expression and survival prediction Kim, WJ; Choi, BR; Noh, JJ; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Choi, CH
    View PubMed
  • FRONT ONCOL 2024 10.3389/fonc.2024.1341228 Combined radiomics-clinical model to predict platinum-sensitivity in advanced high-grade serous ovarian carcinoma using multimodal MRI Na, IY; Noh, JJ; Kim, CK; Lee, JW; Park, H
    View PubMed
  • GLAND SURG 2024 10.21037/gs-23-249 Initial experience with the enhanced recovery after surgery (ERAS) protocols in gynecologic surgery at an urban academic tertiary medical center Kim, WJ; Noh, JJ; Bang, YJ; Yang, MY; Kim, JH; Park, CH; Song, HJ; Kim, JM; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Min, JJ; Kim, CS; Hahm, TS; Lee, YY
    View PubMed
  • CANCER CELL INT 2024 10.1186/s12935-024-03235-2 The anti-tumor effects of AZD4547 on ovarian cancer cells: differential responses based on c-Met and FGF19/FGFR4 expression Lee, YY; Ryu, JY; Cho, YJ; Choi, JY; Choi, JJ; Choi, CH; Sa, JK; Hwang, JR; Lee, JW
    View PubMed
  • NEW ENGL J MED 2023 10.1056/NEJMoa2309169 Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer Moore, KN; Angelergues, A; Konecny, GE; García, Y; Banerjee, S; Lorusso, D; Lee, JY; Moroney, JW; Colombo, N; Roszak, A; Tromp, J; Myers, T; Lee, JW; Beiner, M; Cosgrove, CM; Cibula, D; Martin, LP; Sabatier, R; Buscema, J; Estévez-García, P; Coffman, L; Nicum, S; Duska, LR; Pignata, S; Gálvez, F; Wang, Y; Method, M; Berkenblit, A; Roufai, DB; Van Gorp, T
    View PubMed
  • BIOMED PHARMACOTHER 2023 10.1016/j.biopha.2023.115792 Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3/CCL2 signaling pathway in uterine sarcoma Hwang, JR; Cho, YJ; Ryu, JY; Choi, JY; Choi, JJ; Sa, JK; Kim, HS; Lee, JW
    View PubMed
  • YONSEI MED J 2023 10.3349/ymj.2023.0063 Rechallenge with Anti-PD-1 Inhibitors in Patients with Recurrent Gynecologic Malignancies Kim, M; Chang, CS; Choi, MC; Lee, JW; Park, H; Joo, WD
    View PubMed
  • J GYNECOL ONCOL 2023 10.3802/jgo.2023.34.e58 Anti-cancer effect of fenbendazole- incorporated PLGA nanoparticles in ovarian cancer Chang, CS; Ryu, JY; Choi, JK; Cho, YJ; Choi, JJ; Hwang, JR; Choi, JY; Noh, JJ; Lee, CM; Won, JE; Han, HD; Lee, JW
    View PubMed
  • ANESTH ANALG 2023 10.1213/ANE.0000000000006358 The Effect of Intrathecal Morphine on Postoperative Opioid Consumption in Patients Undergoing Abdominal Surgery for Gynecologic Malignancy: A Randomized Sham-Controlled Trial Bang, YJ; Lee, EK; Kim, CS; Hahm, TS; Jeong, H; Cho, YJ; Noh, JJ; Lee, YY; Choi, CH; Lee, JW; Jeong, JS
    View PubMed
  • ANN SURG ONCOL 2023 10.1245/s10434-023-13868-8 ASO Visual Abstract: Comparison of Minimally Invasive and Open Surgery for the Treatment of Endometrial Cancer with a High Risk of Recurrence: A Propensity-Score-Matching Study in Korea and Taiwan Chang, CS; Lai, YL; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Cheng, WF; Chen, YL; Lee, YY
    View PubMed
  • ANN SURG ONCOL 2023 10.1245/s10434-023-13695-x Comparison of Minimally Invasive and Open Surgery for the Treatment of Endometrial Cancer with a High Risk of Recurrence: A Propensity Score Matching Study in Korea and Taiwan Chang, CS; Lai, YL; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Cheng, WF; Chen, YL; Lee, YY
    View PubMed
  • INT J NANOMED 2023 10.2147/IJN.S394712 Anticancer Evaluation of Methoxy Poly(Ethylene Glycol)-b-Poly(Caprolactone) Polymeric Micelles Encapsulating Fenbendazole and Rapamycin in Ovarian Cancer Shin, YB; Choi, JY; Shin, DH; Lee, JW
    View PubMed
  • NAT COMMUN 2023 10.1038/s41467-023-37768-3 Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA Bae, M; Kim, G; Lee, TR; Ahn, JM; Park, H; Park, SR; Song, KB; Jun, E; Oh, D; Lee, JW; Park, YS; Song, KW; Byeon, JS; Kim, BH; Sohn, JH; Kim, MH; Kim, GM; Chie, EK; Kang, HC; Kong, SY; Woo, SM; Lee, JE; Ryu, JM; Lee, J; Kim, D; Ki, CS; Cho, EH; Choi, JK
    View PubMed
  • BIOMATERIALS 2023 10.1016/j.biomaterials.2023.122087 High-throughput organo-on-pillar (high-TOP) array system for three-dimensional ex vivo drug testing Jun, HR; Kang, HJ; Ju, SH; Kim, JE; Jeon, SY; Ku, BS; Lee, JJ; Kim, M; Kim, MJ; Choi, JJ; Noh, JJ; Kim, HS; Lee, JW; Lee, JK; Lee, DW
    View PubMed
  • CLIN NUCL MED 2023 10.1097/RLU.0000000000004417 Development and Validation of F-18-FDG PET/CT-Based Models for Predicting Successful Complete Cytoreduction During Primary Cytoreductive Surgery for Advanced Ovarian cancer Kim, J; Gil, J; Kim, SI; Hwangbo, S; Noh, JJ; Lee, JW; Cheon, GJ; Kim, JW; Cho, YS; Lee, MR
    View PubMed
  • J VASC INTERV RADIOL 2022 10.1016/j.jvir.2022.10.009 Arteriovenous Malformation Associated with Intravenous Leiomyomatosis of the Uterus: Characteristic CT Findings and Treatment by Embolization and Surgery Kim, JG; Park, YJ; Do, YS; Kim, BG; Lee, JW; Choi, CH; Kim, HC; Park, KB; Hyun, DH
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.996516 Invisible cervical cancers on MRI: Can the type of histology (SCC versus non-SCC) influence surgical planning? Jeon, J; Park, BK; Lee, JW; Choi, CH; Lee, YY; Kim, TJ; Kim, BG
    View PubMed
  • J GYNECOL ONCOL 2022 10.3802/jgo.2022.33.e71 Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy Cho, WK; Kim, HS; Park, W; Chang, CS; Lee, YY; Choi, CH; Kim, TJ; Lee, JW; Kim, BG
    View PubMed
  • INT J GYNECOL CANCER 2022 10.1136/ijgc-2022-003971 Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: implications on risk group stratification Bae, BK; Cho, WK; Kim, BG; Choi, CH; Kim, TJ; Lee, YY; Lee, JW; Park, W
    View PubMed
  • INT J CANCER 2022 10.1002/ijc.34150 Somatic genomic landscape of East Asian epithelial ovarian carcinoma and its clinical implications from prospective clinical sequencing: A Korean Gynecologic Oncology Group study (KGOG 3047) Sa, JK; Kim, J; Kang, S; Kim, SW; Song, T; Shim, SH; Choi, MC; No, JH; Song, JY; Kim, D; Kim, YM; Kim, JH; Lee, JW
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.828 Frequency of Mismatch Repair Deficiency/High Microsatellite Instability and Its Role as a Predictive Biomarker of Response to Immune Checkpoint Inhibitors in Gynecologic Cancers Noh, JJ; Kim, MK; Choi, MC; Lee, JW; Park, H; Jung, SG; Joo, WD; Song, SH; Lee, C
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.926878 Role of reactive thrombocytosis after primary cytoreductive surgery in advanced ovarian cancer Kim, MS; Baek, SH; Noh, JJ; Shim, JI; Kang, JH; Jeong, SY; Choi, CH; Kim, TJ; Lee, JW; Lee, YY
    View PubMed
  • CANCER BIOMARK 2022 10.3233/CBM-210077 Changes in subcellular localization of Lysyl-tRNA synthetase and the 67-kDa laminin receptor in epithelial ovarian cancer metastases Lee, DH; Paik, ES; Cho, YJ; Lee, YY; Lee, B; Lee, EJ; Choi, JJ; Choi, CH; Lee, S; Choi, JW; Lee, JW
    View PubMed
  • CLIN CANCER RES 2022 10.1158/1078-0432.CCR-22-0985 Anticancer Activity of the Combination of Cabozantinib and Temozolomide in Uterine Sarcoma Noh, JJ; Cho, YJ; Ryu, JY; Choi, JJ; Hwang, JR; Choi, JY; Lee, JW
    View PubMed
  • GYNECOL ONCOL 2022 10.1016/j.ygyno.2022.07.011 Impact of bevacizumab and secondary cytoreductive surgery on survival outcomes in platinum-sensitive relapsed ovarian clear cell carcinoma: A multicenter study in Korea Kim, SI; Kim, JH; Noh, JJ; Kim, SH; Kim, TE; Kim, K; Park, JY; Lim, MC; Lee, JW; Kim, JW
    View PubMed
  • INT J GYNECOL CANCER 2022 10.1136/ijgc-2022-003834 Role of salvage radiotherapy for recurrent ovarian cancer Bae, BK; Cho, WK; Lee, JW; Kim, TJ; Choi, CH; Lee, YY; Park, W
    View PubMed
  • CANCERS 2022 10.3390/cancers14163863 The Role of Conization before Radical Hysterectomy in Cervical Cancer including High Risk Factors of Recurrence: Propensity Score Matching Chang, CS; Min, JS; Song, KH; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Lee, YY
    View PubMed
  • GYNECOL ONCOL 2022 10.1016/j.ygyno.2022.03.014 Impact of no residual disease on postoperative computed tomography on survival in patients with optimally debulked advanced high-grade serous ovarian cancer during upfront surgery Lim, H; Shim, JI; Park, SJ; Noh, J; Kim, TM; Lee, M; Choi, CH; Chung, HH; Kim, TJ; Lee, JW; Kim, JW; Kim, BG; Park, NH; Song, YS; Kim, SY; Park, SY; Kim, HS; Lee, YY
    View PubMed
  • GYNECOL ONCOL 2022 10.1016/j.ygyno.2022.02.020 Real-world experience of pembrolizumab and lenvatinib in recurrent endometrial cancer: A multicenter study in Korea Kim, J; Noh, JJ; Lee, TK; Kim, SI; Lee, JY; Lee, JW; Kim, JW
    View PubMed
  • CANCERS 2022 10.3390/cancers14092139 Prognostic Significance of HER3 Expression in Patients with Cervical Cancer Chang, CS; Shim, JI; Byeon, SJ; Lee, EJ; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Choi, CH
    View PubMed
  • GYNECOL ONCOL 2022 10.1016/j.ygyno.2022.03.005 Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer Shim, JI; Ryu, JY; Jeong, SY; Cho, YJ; Choi, JJ; Hwang, JR; Choi, JY; Sa, JK; Lee, JW
    View PubMed
  • TAIWAN J OBSTET GYNE 2022 10.1016/j.tjog.2022.02.024 Clinical outcome of pulmonary lymphangitic carcinomatosis in gynecologic malignancy: A single-institution experience Kim, MS; Jeong, SY; Lee, YY; Choi, CH; Kim, TJ; Kim, BG; Bae, DS; Lee, JW
    View PubMed
  • J IMMUNOTHER CANCER 2022 10.1136/jitc-2021-003928 Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches Won, JE; Byeon, Y; Wi, TI; Lee, CM; Lee, JH; Kang, TH; Lee, JW; Lee, Y; Park, YM; Han, HD
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.023 Effect of Waiting Time from Pathological Diagnosis to Definitive Concurrent Chemoradiation for Cervical Cancer on Overall Survival Noh, KW; Kim, B; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Cho, WK; Park, W; Lee, YY
    View PubMed
  • CANCERS 2022 10.3390/cancers14010224 Utility of 3T MRI in Women with IB1 Cervical Cancer in Determining the Necessity of Less Invasive Surgery Jeong, SY; Park, BK; Choi, CH; Lee, YY; Kim, TJ; Lee, JW; Kim, BG
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.670214 2021 Minimally-Invasive Versus Abdominal Hysterectomy for Endometrial Carcinoma With Glandular or Stromal Invasion of Cervix Jung1, JH; Noh, JJ; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Lee, YY
    View PubMed
  • EUR J GYNAECOL ONCOL 2021 10.31083/j.ejgo.2021.01.2209 2021 Port site implantation of clear cell carcinoma after laparoscopic ovarian cystectomy Noh1, JJ; Choi, KH; Kim, HS; Lee, JW
    View PubMed
  • TAIWAN J OBSTET GYNECOL 2021 10.1016/j.tjog.2020.11.020 2021 Vulvar epithelioid sarcoma: A case report with literature review Noh1, JJ; Jeon, JE; Jung, H; Kim, HS; Lee, YY; Choi, CH; Lee, JW
    View PubMed
  • J GYNECOL ONCOL 2021 10.3802/jgo.2021.32.e94 Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines Cho, HW; Min, KJ; Kwon, SH; Kim, K; Kim, S; Seong, SJ; Song, YJ; Lee, KH; Lee, SW; Lee, JW; Ju, W; Kim, YT; Lee, JK
    View PubMed
  • J GYNECOL ONCOL 2021 10.3802/jgo.2021.32.e90 Comparisons of survival outcomes between bevacizumab and olaparib in BRCA-mutated, platinum-sensitive relapsed ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3052) Kim, SI; Lee, JW; Kim, K; Lee, M; Yoo, J; Choi, MC; Hwangbo, S; Kwak, YH; Lee, JM; Shin, SJ; Shim, SH; Kim, MK
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.770103 Prognostic Relevance of BRCA1 Expression in Survival of Patients With Cervical Cancer Paik, ES; Chang, CS; Chae, YL; Oh, SY; Byeon, SJ; Kim, CJ; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Choi, CH
    View PubMed
  • ACTA BIOMATER 2021 10.1016/j.actbio.2021.09.062 NIR irradiation-controlled drug release utilizing injectable hydrogels containing gold-labeled liposomes for the treatment of melanoma cancer Won, JE; Wi, TI; Lee, CM; Lee, JH; Kang, TH; Lee, JW; Shin, BC; Lee, Y; Park, YM; Han, HD
    View PubMed
  • CANCERS 2021 10.3390/cancers13225670 Machine Learning for Recurrence Prediction of Gynecologic Cancers Using Lynch Syndrome-Related Screening Markers Kim, BW; Choi, MC; Kim, MK; Lee, JW; Kim, MT; Noh, JJ; Park, H; Jung, SG; Joo, WD; Song, SH; Lee, C
    View PubMed
  • BIOMATERIALS 2021 10.1016/j.biomaterials.2021.121189 The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis Kim, J; Shim, MK; Cho, YJ; Jeon, S; Moon, Y; Choi, J; Kim, J; Lee, J; Lee, JW; Kim, K
    View PubMed
  • CANCER SCI 2021 10.1111/cas.15166 Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer Paik, ES; Heo, EJ; Choi, CH; Kim, JH; Kim, JW; Kim, YM; Park, SY; Lee, JW; Kim, JW; Kim, BG
    View PubMed
  • J GYNECOL ONCOL 2021 10.3802/jgo.2021.32.e72 Significance of serum CA125 level in surgically resected cervical adenocarcinoma with adverse features Kim, N; Park, W; Cho, WK; Bae, DS; Kim, BG; Lee, JW; Choi, CH; Kim, TJ; Lee, YY
    View PubMed
  • CANCER RES TREAT 2021 10.4143/crt.2020.1251 Early Metabolic Response Assessed Using F-18-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer Kim, N; Park, W; Cho, WK; Bae, DS; Kim, BG; Lee, JW; Kim, TJ; Choi, CH; Lee, YY; Cho, YS
    View PubMed
  • TAIWAN J OBSTET GYNE 2021 10.1016/j.tjog.2021.05.029 Single-port access (SPA) laparoscopic myomectomy with uterine artery ligation via a retroperitoneal approach is feasible in women with large uterine leiomyoma Noh, JJ; Kim, J; Paik, ES; Kang, JH; Jeong, SY; Choi, CH; Lee, YY; Lee, JW; Kim, BG; Bae, DS; Kim, TJ
    View PubMed
  • CELL DEATH DIS 2020 10.1038/s41419-020-03242-x 2020 Chloroquine reverses chemoresistance via upregulation of p21(WAF1/CIP1) and autophagy inhibition in ovarian cancer Hwang1, JR; Kim, WY; Cho, YJ; Ryu, JY; Choi, JJ; Jeong, SY; Kim, MS; Kim, JH; Paik, ES; Lee, YY; Han, HD; Lee, JW
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9113471 2020 Prognostic Significance of Tumor Regression Rate during Concurrent Chemoradiotherapy in Locally Advanced Cervix Cancer Analysis by Radiation Phase and Histologic Type Kang1, JH; Cho, WK; Yeo, HJ; Jeong, SY; Noh, JJ; Shim, JI; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Park, W; Choi, CH
    View PubMed
  • CANCERS 2020 10.3390/cancers12113188 2020 Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer A Korean Multi-Center Retrospective Study (KGOG1041) Choi1, MC; Kim, YM; Lee, JW; Lee, YJ; Suh, DH; Lee, SJ; Lee, TS; Lee, M; Park, DC; Kim, MK; Lee, JM; Shim, SH; Jeon, S; Min, KJ; Kim, MK; Kim, BW; Park, JY; Kim, BG; Kim, DY; Kim, MH; Kim, HS; Lee, JY
    View PubMed
  • INT J NANOMEDICINE 2020 10.2147/IJN.S272319 2020 Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma Wi1, TI; Won, JE; Lee, CM; Lee, JW; Kang, TH; Shin, BC; Han, HD; Park, YM
    View PubMed
  • PHARMACEUTICS 2020 10.3390/pharmaceutics12100987 2020 Anti-Cancer Activity of As4O6 and its Efficacy in a Series of Patient-Derived Xenografts for Human Cervical Cancer Noh1, JJ; Kim, MS; Cho, YJ; Jeong, SY; Lee, YY; Ryu, JY; Choi, JJ; Bae, I; Wu, Z; Kim, BG; Hwang, JR; Lee, JW
    View PubMed
  • CURR PROB CANCER 2020 10.1016/j.currproblcancer.2020.100557 2020 Triplet chemotherapy vs doublet chemotherapy plus bevacizumab in metastatic, recurrent, and persistent cervical cancer Choi1, HJ; Lee, YY; Choi, CH; Kim, TJ; Lee, JW; Bae, JH; Bae, DS; Kim, BG
    View PubMed
  • FRONT ONCOL 2020 10.3389/fonc.2020.583515 2020 Feasibility of Single-Port Access (SPA) Laparoscopy for Large Ovarian Tumor Suspected to Be Borderline Ovarian Tumor Kang1, JH; Noh, JJ; Jeong, SY; Shim, JI; Lee, YY; Choi, CH; Lee, JW; Kim, BG; Bae, DS; Kim, HS; Kim, TJ
    View PubMed
  • GUT LIVER 2020 10.5009/gnl20187 2020 Anxiety and Depression in Patients with Inflammatory Bowel Diseases The First Step toward Proper Management Lee1, JW
    View PubMed
  • EUR J CANCER 2020 10.1016/j.ejca.2020.03.030 2020 Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R) Choi1, MC; Chung, YS; Lee, JW; Kwon, BS; Park, BK; Kim, SI; Shim, SH; Lee, KB; Seong, SJ; Lee, SJ; Lee, SH; Yoo, HJ; Song, T; Kim, MK; Baek, MH; Kang, S; Kim, YM
    View PubMed
  • THER ADV MED ONCOL 2020 10.1177/1758835920926796 2020 First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients Kim1, ST; Hong, JY; Park, SH; Park, JO; Park, YW; Park, N; Lee, H; Hong, SH; Lee, SJ; Song, SW; Kim, K; Park, YS; Lim, HY; Kang, WK; Nam, H; Lee, JW; Park, K; Kim, KM; Lee, J
    View PubMed
  • HELICOBACTER 2020 10.1111/hel.12685 2020 Annual eradication rate of bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: A 15-year prospective study at a tertiary hospital in Korea Yoon1, K; Kim, N; Lee, JW; Yoon, H; Shin, CM; Park, YS; Lee, DH
    View PubMed
  • INFLAMM BOWEL DIS 2020 10.1093/ibd/izz317 2020 Novel Histone Deacetylase 6 Inhibitor CKD-506 Inhibits NF-kappa B Signaling in Intestinal Epithelial Cells and Macrophages and Ameliorates Acute and Chronic Murine Colitis Lee1, JW; Lee, SM; Chun, J; Im, JP; Seo, SK; Ha, N; Choi, YI; Kim, JS
    View PubMed
  • J CONTROL RELEASE 2020 10.1016/j.jconrel.2020.02.013 2020 KSP siRNA/paclitaxel-loaded PEGylated cationic liposomes for overcoming resistance to KSP inhibitors: Synergistic antitumor effects in drug-resistant ovarian cancer Lee1, J; Cho, YJ; Lee, JW; Ahn, HJ
    View PubMed
  • Front Oncol 2020 10.3389/fonc.2020.00451 2020 Comparison of Laparoscopy and Laparotomy for Para-Aortic Lymphadenectomy in Women With Presumed Stage I-II High-Risk Endometrial Cancer Paik1, ES; Baek, SH; Kang, JH; Jeong, SY; Kim, MS; Kim, WY; Lee, YY; Choi, CH; Lee, JW; Kim, BG; Bae, DS; Kim, TJ
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2019.328 2020 Pretreatment Lymph Node Metastasis as a Prognostic Significance in Cervical Cancer: Comparison between Disease Status Jeong1, SY; Park, H; Kim, MS; Kang, JH; Paik, ES; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9041137 2020 Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using cis-eQTL Analysis Kim1, J; Chung, JY; Hwang, JR; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH; Hewitt, SM
    View PubMed
  • J GYNECOL ONCOL 2020 10.3802/jgo.2020.31.e15 2020 Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study Park1, SJ; Kim, J; Kim, HS; Lee, JW; Chang, H; Lee, KH; Kim, DY; Kim, S; Chang, SJ; Han, SS; Park, SY; Shim, SH
    View PubMed
  • J BIOMED NANOTECHNOL 2020 10.1166/jbn.2020.2883 2020 Selective Tumor-Specific Antigen Delivery to Dendritic Cells Using Mannose-Labeled Poly(d,l-lactide-co-glycolide) Nanoparticles for Cancer Immunotherapy Wi1, TI; Byeon, Y; Won, JE; Lee, JM; Kang, TH; Lee, JW; Lee, YJ; Sood, AK; Han, HD; Park, YM
    View PubMed
  • J MINIM INVAS GYN 2020 10.1016/j.jmig.2019.04.005 2020 In Vivo Comparison of MONOFIX, A Novel Barbed Suture with a Triangular Stopper, with Pre-existing Products in a Porcine Model Kim1, J; Eom, HJ; Shin, H; Jeong, SY; Kim, MS; Yoon, HS; In, CH; Kim, BG; Bae, DS; Lee, JW
    View PubMed
  • BIOCHEM PHARMACOL 2020 10.1016/j.bcp.2019.113735 2020 Cytoplasmic expression of EGFR shRNA using a modified T7 autogene-based hybrid mRNA/DNA system induces long-term EGFR silencing and prolongs antitumor effects Seraj1, S; Cho, YJ; Lee, JW; Ahn, HJ
    View PubMed
  • GYNECOL ONCOL 2020 10.1016/j.ygyno.2019.11.004 2020 CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer Kim1, J; Cho, YJ; Ryu, JY; Hwang, I; Han, HD; Ahn, HJ; Kim, WY; Cho, H; Chung, JY; Hewitt, SM; Kim, JH; Kim, BG; Bae, DS; Choi, CH; Lee, JW
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9010147 2020 Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16-or 18-Positive Recurrent Cervical Cancer Choi1, CH; Choi, HJ; Lee, JW; Kang, ES; Cho, D; Park, BK; Kim, YM; Kim, DY; Seo, H; Park, M; Kim, W; Choi, KY; Oh, T; Kang, CY; Kim, BG
    View PubMed
  • J Minim Invasive Gynecol. 2019 Apr 6. pii: S1553-4650(19)30154-2. doi: 10.1016/j.jmig.2019.04.005. [Epub ahead of print] 2019 In Vivo Comparison of MONOFIX, A Novel Barbed Suture with a Triangular Stopper, with Pre-existing Products in a Porcine Model Kim J1, Eom HJ, Shin H, Jeong SY, Kim MS, Yoon HS, In CH, Kim BG, Bae DS, Lee JW.
    View PubMed
  • J Gynecol Oncol. 2019 Jul;30(4):e65. doi: 10.3802/jgo.2019.30.e65. Epub 2019 Mar 11. 2019 Prediction of Survival Outcomes in Patients with Epithelial Ovarian Cancer using Machine Learning Methods E Sun Paik1, Jeong-Won Lee, Jeong-Yeol Park, Ju-Hyun Kim, Mijung Kim, Tae-Joong Kim, Chel Hun Choi, Byoung-Gie Kim, Duk-Soo Bae, Sung Wook Seo
    View PubMed
  • Genome Biol. 2019 Nov 26;20(1):253. doi: 10.1186/s13059-019-1848-3. 2019 Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers Sa JK1, Hwang JR, Cho YJ, Ryu JY, Choi JJ, Jeong SY, Kim J, Kim MS, Paik ES, Lee YY, Choi CH, Kim TJ, Kim BG, Bae DS, Lee Y, Her NG, Shin YJ, Cho HJ, Kim JY, Seo YJ, Koo H, Oh JW1, Lee T, Kim HS, Song SY, Bae JS, Park WY, Han HD, Ahn HJ, Sood AK, Rabadan R, Lee JK, Nam DH, Lee JW.
    View PubMed
  • Obstet Gynecol Sci. 2019 Mar;62(2):103-111. doi: 10.5468/ogs.2019.62.2.103. Epub 2019 Feb 12 2019 Prognostic factors for recurrence and survival in uterine leiomyosarcoma: Korean single center experience with 50 cases E Sun Paik1, Jae Hong Kang, Jihye Kim, Yeon-Joo Lee, Chel Hun Choi, Tae-Joong Kim, Byoung-Gie Kim, Duk-Soo Bae, Jeong-Won Lee
    View PubMed
  • J OVARIAN RES 2019 10.1186/s13048-019-0602-5 2019 Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer Jeong1, SY; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Lee, YY
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-019-51959-3 2019 Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer Lee1, YY; Cho, YJ; Shin, SW; Choi, C; Ryu, JY; Jeon, HK; Choi, JJ; Hwang, JR; Choi, CH; Kim, TJ; Kim, BG; Bae, DS; Park, W; Lee, JW
    View PubMed
  • EUR J CANCER CARE 2019 10.1111/ecc.13089 2019 Influence of time lapse after cancer diagnosis on the association between unmet needs and quality of life in family caregivers of Korean cancer patients Shin1, J; Ko, H; Lee, JW; Kim, K; Song, YM
    View PubMed
  • J VIROL METHODS 2019 10.1016/j.jviromet.2019.04.012 2019 Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay Cho1, HW; Ouh, YT; Hong, JH; Min, KJ; So, KA; Kim, TJ; Paik, ES; Lee, JW; Moon, JH; Lee, JK
    View PubMed
  • J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e65 2019 Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods Paik1, ES; Lee, JW; Park, JY; Kim, JH; Kim, M; Kim, TJ; Choi, CH; Kim, BG; Bae, DS; Seo, SW
    View PubMed
  • BMC CANCER 2019 10.1186/s12885-019-5514-7 2019 Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708) Chung1, YS; Park, SY; Lee, JY; Park, JY; Lee, JW; Kim, HS; Suh, DS; Kim, YH; Lee, JM; Kim, M; Choi, MC; Shim, SH; Lee, KH; Song, T; Hong, JH; Lee, WM; Lee, B; Lee, IH
    View PubMed
  • ARCH GYNECOL OBSTET 2019 10.1007/s00404-018-4996-x 2019 Functional loss in daily activity in ovarian cancer patients undergoing chemotherapy Cheong1, IY; Yoo, JS; Chung, SH; Park, SY; Song, HJ; Lee, JW; Hwang, JH
    View PubMed
  • J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e31 2019 Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline Min1, KJ; Kwon, SH; Kim, K; Kim, S; Kim, HJ; Seong, SJ; Song, YJ; Lee, KH; Lee, SW; Lee, JW; Chang, SJ; Ju, W; Kim, YT; Lee, JK
    View PubMed
  • GYNECOL ONCOL 2019 10.1016/j.ygyno.2018.10.031 2019 Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041) Lee1, JY; Park, JY; Park, SY; Lee, JW; Kim, JW; Kim, YB; Jeong, DH; Lee, KB; Kim, TH; Lee, IH; Choi, MC; Kim, KH; Kim, YM; Lee, YJ; Kang, S; Pujade-Lauraine, E; Shin, SJ; Hong, DG; Shim, SH; Kim, YH; Song, T; Bae, J; Lee, JM; Lee, SH; Lee, EJ; Park, SI; Lee, SJ; Lee, C; Lee, TS; Chang, SJ; Kim, MK
    View PubMed
  • J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e11 2019 Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff? Kim1, J; Chang, Y; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH
    View PubMed
  • J Clin Oncol. 2018 Sep 20;36(27):2778-2786. doi: 10.1200/JCO.2018.77.7912. Epub 2018 Aug 3. 2018 Disparities in cervical cancer screening among women with disabilities: a national database study in South Korea Dong Wook Shin1, Jeong-Won Lee, Jin Hyung Jung, Kyungdo Han, So Young Kim, Kui Son Choi, Jong eon Park, Jong Hyock Park
    View PubMed
  • INT J GYNECOL OBSTET 2018 10.1002/ijgo.12653 2018 Impact of interval from primary cytoreductive surgery to initiation of adjuvant chemotherapy in advanced epithelial ovarian cancer Lee1, YY; Lee, JW; Lu, L; Xu, W; Kollara, A; Brown, T; Heo, EJ; May, T
    View PubMed
  • DRUG DELIV 2018 10.1080/10717544.2018.1480672 2018 Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer Kim1, GH; Won, JE; Byeon, Y; Kim, MG; Wi, TI; Lee, JM; Park, YY; Lee, JW; Kang, TH; Jung, ID; Shin, BC; Ahn, HJ; Lee, YJ; Sood, AK; Han, HD; Park, YM
    View PubMed
  • CANCER RES 2018 10.1158/0008-5472.CAN-17-3871 2018 CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer Byeon1, Y; Lee, JW; Choi, WS; Won, JE; Kim, GH; Kim, MG; Wi, TI; Lee, JM; Kang, TH; Jung, ID; Cho, YJ; Ahn, HJ; Shin, BC; Lee, YJ; Sood, AK; Han, HD; Park, YM
    View PubMed
  • Front Oncol 2018 10.3389/fonc.2018.00465 2018 Genomic Network-Based Analysis Reveals Pancreatic Adenocarcinoma Up-Regulating Factor-Related Prognostic Markers in Cervical Carcinoma Kim1, J; Chung, JY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH; Hewitt, SM
    View PubMed
  • NAT GENET 2018 10.1038/s41588-018-0209-6 2018 Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy Lee1, JK; Liu, ZQ; Sa, JK; Shin, S; Wang, JG; Bordyuh, M; Cho, H; Elliott, O; Chu, T; Choi, SW; Rosenbloom, DIS; Lee, IH; Shin, YJ; Kang, HJ; Kim, D; Kim, SY; Sim, MH; Kim, J; Lee, T; Seo, YJ; Shin, H; Lee, M; Kim, SH; Kwon, YJ; Oh, JW; Song, M; Kim, M; Kong, DS; Choi, JW; Seol, HJ; Lee, JI; Kim, ST; Park, JO; Kim, KM; Song, SY; Lee, JW; Kim, HC; Lee, JE; Choi, MG; Seo, SW; Shim, YM; Zo, JI; Jeong, BC; Yoon, Y; Ryu, GH; Kim, NKD; Bae, JS; Park, WY; Lee, J; Verhaak, RGW; Iavarone, A; Lee, J; Rabadan, R; Nam, DH
    View PubMed
  • EUR J OBSTET GYN R B 2018 10.1016/j.ejogrb.2018.06.034 2018 The role of appendectomy in patients with mucinous borderline ovarian tumors Song1, T; Kim, MK; Jung, YW; Yun, BS; Seong, SJ; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS
    View PubMed
  • INT J GYNECOL CANCER 2018 10.1097/IGC.0000000000001316 2018 Response to Combination Chemotherapy With Paclitaxel/Ifosfamide/Platinum Versus Paclitaxel/Platinum for Patients With Metastatic, Recurrent, or Persistent Carcinoma of the Uterine Cervix A Retrospective Analysis Choi1, HJ; Paik, ES; Choi, CH; Kim, TJ; Lee, YY; Lee, JW; Bae, DS; Kim, BG
    View PubMed
  • J GYNECOL ONCOL 2018 10.3802/jgo.2018.29.e56 2018 Practice guidelines for management of ovarian cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement Suh1, DH; Chang, SJ; Song, T; Lee, S; Kang, WD; Lee, SJ; Roh, JW; Joo, WD; Yoon, JH; Jeong, DH; Kim, HS; Lee, SJ; Ji, YI; Kim, HJ; Lee, JW; Kim, JW; Bae, DS
    View PubMed
  • EUR J NUCL MED MOL I 2018 10.1007/s00259-018-3975-6 2018 Preoperative [F-18]FDG PET/CT tumour heterogeneity index in patients with uterine leiomyosarcoma: a multicentre retrospective study Lee1, JW; Park, JY; Lee, HJ; Lee, JJ; Moon, SH; Kang, SY; Cheon, GJ; Chung, HH
    View PubMed
  • CANCER RES TREAT 2018 10.4143/crt.2017.104 2018 Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer Paik1, ES; Choi, HJ; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH
    View PubMed
  • J GYNECOL ONCOL 2018 10.3802/jgo.2018.29.e18 2018 Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis Paik1, ES; Kim, TJ; Choi, CH; Kim, BG; Bae, DS; Lee, JW
    View PubMed
  • J GYNECOL ONCOL 2018 10.3802/jgo.2018.29.e13 2018 Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer Paik1, ES; Kim, JH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH
    View PubMed
  • GYNECOL OBSTET INVES 2018 10.1159/000475817 2018 Elevated Preoperative CA125 or CA19-9 in Borderline Ovarian Tumors: Could It Be Suggestive of Advanced Stage or a Poor Prognosis? Song1, T; Lee, DH; Jung, YW; Yun, BS; Seong, SJ; Choi, CH; Lee, JW; Bae, DS; Kim, BG
    View PubMed
  • PLoS One 2018 10.1371/journal.pone.0189847 2018 Can simple trachelectomy or conization show comparable survival rate compared with radical trachelectomy in IA1 cervical cancer patients with lymphovascular space invasion who wish to save fertility? A systematic review and guideline recommendation Shim1, SH; Lim, MC; Kim, HJ; Lee, M; Nam, EJ; Lee, JY; Lee, YY; Lee, KB; Park, JY; Kim, YH; Ki, KD; Song, YJ; Chung, HH; Kim, S; Lee, JW; Kim, JW; Bae, DS; Lee, JM
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.322 2017 Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies Heo1, EJ; Cho, YJ; Cho, WC; Hong, JE; Jeon, HK; Oh, DY; Choi, YL; Song, SY; Choi, JJ; Bae, DS; Lee, YY; Choi, CH; Kim, TJ; Park, WY; Kim, BG; Lee, JW
    View PubMed
  • EUR RADIOL 2017 10.1007/s00330-017-4765-4 2017 Preservation of the endometrial enhancement after magnetic resonance imaging-guided high-intensity focused ultrasound ablation of submucosal uterine fibroids Kim1, YS; Kim, TJ; Lim, HK; Rhim, H; Jung, SH; Ahn, JH; Lee, JW; Kim, BG
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.034 2017 Proton. Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer Song1, T; Jeon, HK; Hong, JE; Choi, JJ; Kim, TJ; Choi, CH; Bae, DS; Kim, BG; Lee, JW
    View PubMed
  • SCI REP-UK 2017 10.1038/s41598-017-06510-7 2017 The anti-cancer effects of itraconazole in epithelial ovarian cancer Choi1, CH; Ryu, JY; Cho, YJ; Jeon, HK; Choi, JJ; Ylaya, K; Lee, YY; Kim, TJ; Chung, JY; Hewitt, SM; Kim, BG; Bae, DS; Lee, JW
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.282 2017 Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer Paik1, ES; Sohn, I; Baek, SY; Shim, M; Choi, HJ; Kim, TJ; Choi, CH; Lee, JW; Kim, BG; Lee, YY; Bae, DS
    View PubMed
  • JOURNAL OF GYNECOLOGIC ONCOLOGY, MAY 2017, 28(3), DOI: 10.3802/jgo.2017.28.e28 2017 Prognostic significance of preoperative F-18-FDG PET/CT in uterine leiomyosarcoma Park JY1, Lee JW, Lee HJ, Lee JJ, Moon SH, Kang SY, Cheon GJ, Chung HH
    View PubMed
  • Int J Gynecol Cancer. 2017 Mar;27(3):507-513. doi: 10.1097/IGC.0000000000000909. 2017 Parametrial Involvement on Magnetic Resonance Imaging Has No Effect on the Survival of Early-Stage Cervical Cancer Patients Yang K11, Park W, Huh SJ, Park BK, Kim CK, Kim BG, Bae DS, Lee JW.
    View PubMed
  • J Gynecol Oncol. 2017 Jan;28(1):e12. doi: 10.3802/jgo.2017.28.e12. Epub 2016 Oct 27. 2017 Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement Lee SW11, Lee TS2, Hong DG3, No JH4, Park DC5, Bae JM6, Seong SJ7, Shin SJ8, Ju W9, Lee KH10, Lee YK11, Cho H12, Lee C13, Paek J14, Kim HJ15, Lee JW16, Kim JW17, Bae DS16.
    View PubMed
  • Sci Rep. 2016 Dec 5;6:38502. doi: 10.1038/srep38502. 2016 c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma Kim HJ11, Yoon A2, Ryu JY2, Cho YJ2, Choi JJ2, Song SY3, Bang H3, Lee JS4, Cho WC5, Choi CH2, Lee JW2,6,7, Kim BG2, Bae DS2.
    View PubMed
  • Aust N Z J Obstet Gynaecol. 2016 Dec;56(6):639-647. doi: 10.1111/ajo.12529. Epub 2016 Sep 9. 2016 Timing and patterns of recurrence in epithelial ovarian cancer patients with no gross residual disease after primary debulking surgery Paik ES11, Lee YY1, Shim M1, Choi HJ1, Kim TJ1, Choi CH1, Lee JW1, Kim BG1, Bae DS1.
    View PubMed
  • Cancer Biomark. 2016;17(4):419-425. doi: 10.3233/CBM-160658. 2016 Preoperative multiplication of neutrophil and monocyte counts as a prognostic factor in epithelial ovarian cancer Paik ES1, Shim M, Choi HJ, Lee YY, Kim TJ, Choi CH, Lee JW, Kim BG, Bae DS.
    View PubMed
  • Sci Rep. 2016 Dec 2;6:38348. doi: 10.1038/srep38348. 2016 In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy Han HD11, Byeon Y1, Jang JH2, Jeon HN1, Kim GH1, Kim MG1, Pack CG3, Kang TH1, Jung ID1, Lim YT4, Lee YJ5, Lee JW6, Shin BC7, Ahn HJ8, Sood AK9,10,11, Park YM1.
    View PubMed
  • Anticancer Res. 2016 Dec;36(12):6381-6388. 2016 Dynamin 2 Inhibitors as Novel Therapeutic Agents Against Cervical Cancer Cells Lee YY11, Jeon HK2, Lee J3, Hong JE2, Do IG4, Choi CH2, Kim TJ2, Kim BG2, Bae DS2, Kim YC3, Lee JW5.
    View PubMed
  • J Korean Med Sci. 2016 Dec;31(12):1969-1975. doi: 10.3346/jkms.2016.31.12.1969. 2016 Development and Validation of the Korean Version of Hand-Foot Skin Reaction and Quality of Life Questionnaire (HF-QoL-K) Nam SH11, Choi HJ2, Kang WD3, Kim SM3, Lim MC4, Park SY4, Kim JS5, Kim BG2, Bae DS2, Lee JW2, Kim TJ2, Song T6.
    View PubMed
  • Sci Rep. 2016 Dec 23;6:39334. doi: 10.1038/srep39334. 2016 The C-terminus of IGFBP-5 suppresses tumor growth by inhibiting angiogenesis Hwang JR11, Cho YJ2,3, Lee Y1, Park Y1, Han HD4, Ahn HJ5, Lee JH6, Lee JW2,3,7.
    View PubMed
  • Gynecol Oncol. 2016 Nov;143(2):252-257. doi: 10.1016/j.ygyno.2016.08.321. Epub 2016 Aug 25. 2016 Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis Paik ES11, Shim M1, Choi HJ1, Lee YY2, Kim TJ1, Lee JW1, Kim BG1, Bae DS1, Choi CH3.
    View PubMed
  • Eur Radiol. 2016 Nov;26(11):4148-4154. Epub 2016 Feb 16. 2016 Prognostic value of total lesion glycolysis on preoperative F-18-FDG PET/CT in patients with uterine carcinosarcoma Lee JW11,2, Heo EJ1, Moon SH3, Lee H4, Cheon GJ4, Lee M5, Kim HS5, Chung HH6.
    View PubMed
  • Int J Nanomedicine. 2016 Nov 2;11:5729-5742. eCollection 2016. 2016 Toll-like receptor 3-induced immune response by poly(D, L-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy Han HD11, Byeon Y1, Kang TH1, Jung ID1, Lee JW2, Shin BC3, Lee YJ4, Sood AK5, Park YM1.
    View PubMed
  • INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9(10):19654-19663 2016 Pulmonary benign metastasizing leiomyoma: clinical and therapeutic analyses of 11 patients treated at a single institution Kim HS1, Yoon G, Lee JS, Han J, Song SY, Kim BG, Bae DS, Lee JW
    View PubMed
  • J Gynecol Oncol. 2016 Sep;27(5):e46. doi: 10.3802/jgo.2016.27.e46. Epub 2016 May 9. 2016 Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer Paik ES11, Kim TJ2, Lee YY1, Choi CH1, Lee JW1, Kim BG1, Bae DS1.
    View PubMed
  • Int J Gynecol Cancer. 2016 Sep;26(7):1252-7. doi: 10.1097/IGC.0000000000000762. 2016 Long-term Outcomes of MRI Stage IIB Cervical Cancer Yoon A11, Park JJ, Park BK, Lee YY, Paik ES, Choi CH, Kim TJ, Kim CK, Lee JW, Bae DS, Kim BG.
    View PubMed
  • BMC Cancer. 2016 Jul 11;16:448. doi: 10.1186/s12885-016-2459-y. 2016 Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer Choi CH11,2, Chung JY1, Chung EJ3, Sears JD1, Lee JW2, Bae DS4, Hewitt SM5.
    View PubMed
  • J Gynecol Oncol. 2016 May;27(3):e27. doi: 10.3802/jgo.2016.27.e27. 2016 Time-lapse imaging of sentinel lymph node using indocyanine green with near-infrared fluorescence imaging in early endometrial cancer Choi HJ11, Kim TJ2, Lee YY1, Lee JW1, Kim BG1, Bae DS1.
    View PubMed
  • J Gynecol Oncol. 2016 May;27(3):e24. doi: 10.3802/jgo.2016.27.e24. 2016 Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer Paik ES11, Lee YY1, Kim TJ1, Choi CH1, Lee JW2, Kim BG1, Bae DS1.
    View PubMed
  • J Gynecol Oncol. 2016 May;27(3):e30. doi: 10.3802/jgo.2016.27.e30. 2016 Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline Min KJ11, Kwon SH2, Kim S3, Kim HJ4, Seong SJ5, Song YJ6, Shin JW7, Lee KH8, Lim MC9, Chung HH10, Ju W11, Hong JH1, Lee JW12, Kim JW10, Bae DS12, Lee JK13.
    View PubMed
  • Mol Cancer Ther. 2016 Apr;15(4):618-27. doi: 10.1158/1535-7163.MCT-15-0733-T. Epub 2016 Feb 9. 2016 Linalool-Incorporated Nanoparticles as a Novel Anticancer Agent for Epithelial Ovarian Carcinoma Han HD11, Cho YJ2, Cho SK3, Byeon Y1, Jeon HN1, Kim HS4, Kim BG5, Bae DS5, Lopez-Berestein G6, Sood AK7, Shin BC8, Park YM9, Lee JW10.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2016 Apr;199:208-12. doi: 10.1016/j.ejogrb.2015.07.018. Epub 2015 Aug 20. 2016 Women with double primary cancers of the colorectum and endometrium: do they have Lynch syndrome Song T11, Kim MK2, Lee YY3, Choi CH3, Kim TJ3, Lee JW3, Bae DS3, Kim BG4.
    View PubMed
  • JSLS. 2016 Apr-Jun;20(2). pii: e2016.00001. doi: 10.4293/JSLS.2016.00001 2016 Retroperitoneal Approach in Single-Port Laparoscopic Hysterectomy Kim TH11, Kim CJ1, Kim TJ2, Lee YY2, Choi CH2, Lee JW2, Bae DS2, Kim BG2.
    View PubMed
  • J Gynecol Oncol. 2016 Mar;27(2):e20. doi: 10.3802/jgo.2016.27.e20. 2016 Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer Park JY11, Heo EJ1, Lee JW2, Lee YY1, Kim TJ1, Kim BG1, Bae DS1.
    View PubMed
  • Radiology. 2016 Mar;278(3):925-35. doi: 10.1148/radiol.2015150608. Epub 2015 Aug 27. 2016 Uterine Fibroids: Correlation of T2 Signal Intensity with Semiquantitative Perfusion MR Parameters in Patients Screened for MR-guided High-Intensity Focused Ultrasound Ablation Kim YS11, Lee JW1, Choi CH1, Kim BG1, Bae DS1, Rhim H1, Lim HK1.
    View PubMed
  • Arch Gynecol Obstet. 2016 Jan;293(1):157-62. doi: 10.1007/s00404-015-3801-3. Epub 2015 Jul 9. 2016 Clinical outcomes of primary surgical treatment for acquired vulvar lymphangioma circumscriptum Yoon G11, Kim HS2, Lee YY3, Kim TJ3, Choi CH3, Kim BG3, Bae DS3, Hwang JH4, Lee JW5.
    View PubMed
  • Carcinogenesis. 2015 Dec;36(12):1561-71. doi: 10.1093/carcin/bgv140. Epub 2015 Oct 6. 2015 Restoration of paclitaxel resistance by CDK1 intervention in drug-resistant ovarian cancer Bae T1, Weon KY1, Lee JW2, Eum KH3, Kim S4, Choi JW5.
    View PubMed
  • Oncotarget. 2015 Nov 3;6(34):36219-30. doi: 10.18632/oncotarget.5283. 2015 HER2 as a novel therapeutic target for cervical cancer Oh DY11,2,3, Kim S1, Choi YL1,2,3, Cho YJ4, Oh E2,3, Choi JJ4, Jung K3, Song JY2, Ahn SE2, Kim BG4, Bae DS4, Park WY3,5, Lee JW2,3,4, Song S1,2.
    View PubMed
  • Oncotarget. 2015 Oct 27;6(33):35040-50. doi: 10.18632/oncotarget.5319. 2015 Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma Lee YY11, Jeon HK1, Hong JE1, Cho YJ1, Ryu JY1, Choi JJ1, Lee SH2, Yoon G3, Kim WY4, Do IG5, Kim MK6, Kim TJ1, Choi CH1, Lee JW1, Bae DS1, Kim BG1.
    View PubMed
  • J Gynecol Oncol. 2015 Oct;26(4):270-6. doi: 10.3802/jgo.2015.26.4.270. Epub 2015 Jul 17. 2015 Pulmonary metastasectomy in uterine malignancy: outcomes and prognostic factors Paik ES11, Yoon A1, Lee YY1, Kim TJ1, Lee JW1, Bae DS1, Kim BG2.
    View PubMed
  • Oncotarget. 2015 Oct 13;6(31):31030-8. doi: 10.18632/oncotarget.5208. 2015 Transcriptome analysis indicates TFEB1 and YEATS4 as regulatory transcription factors for drug resistance of ovarian cancer Kim YR11, Park MS2, Eum KH3, Kim J3, Lee JW4, Bae T5, Lee DH6, Choi JW3,7.
    View PubMed
  • Oncotarget. 2015 Sep 29;6(29):26746-56. doi: 10.18632/oncotarget.4818. 2015 Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer Kim HS11, Yoon G2, Ryu JY3, Cho YJ3, Choi JJ3, Lee YY3, Kim TJ3, Choi CH3, Song SY4, Kim BG3, Bae DS3, Lee JW3,5.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2015 Jul;190:48-51. doi: 10.1016/j.ejogrb.2015.04.014. Epub 2015 May 1. 2015 A prospective comparative study of cosmetic satisfaction for three different surgical approaches Song T11, Park JY2, Kim TJ3, Lee YY2, Choi CH2, Lee JW2, Bae DS2, Kim BG2.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2015 Jul;190:26-30. doi: 10.1016/j.ejogrb.2015.04.005. Epub 2015 Apr 16. 2015 The effect of coexisting squamous cell lesions on prognosis in patients with cervical adenocarcinoma in situ Song T11, Lee YY2, Choi CH2, Kim TJ2, Lee JW2, Bae DS2, Kim BG3.
    View PubMed
  • Int J Cancer. 2015 Jul 1;137(1):221-9. doi: 10.1002/ijc.29362. Epub 2014 Dec 8. 2015 Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer Lee JW11, Ryu JY, Yoon G, Jeon HK, Cho YJ, Choi JJ, Song SY, Do IG, Lee YY, Kim TJ, Choi CH, Kim BG, Bae DS.
    View PubMed
  • Int J Gynecol Cancer. 2015 Jul;25(6):1051-7. doi: 10.1097/IGC.0000000000000407. 2015 Perioperative Outcomes of Radical Trachelectomy in Early-Stage Cervical Cancer Vaginal Versus Laparoscopic Approaches Yoon A11, Choi CH, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • J Gynecol Oncol. 2015 Jul;26(3):222-6. doi: 10.3802/jgo.2015.26.3.222. 2015 Robotic high para-aortic nymph node dissection with high port placement using same port for pelvic surgery in gynecologic cancer patients Kim TJ11, Yoon G2, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG3.
    View PubMed
  • Int J Clin Exp Pathol. 2015 May 1;8(5):5318-26. eCollection 2015. 2015 Mesothelial cell inclusions in pelvic and para-aortic lymph nodes: a clinicopathologic analysis Kim HS11, Yoon G2, Lee YY3, Kim TJ3, Choi CH3, Lee JW3, Kim BG3, Bae DS3, Song SY4.
    View PubMed
  • Int J Gynecol Cancer. 2015 May;25(4):688-93. doi: 10.1097/IGC.0000000000000404. 2015 Correlation Between Location of Transposed Ovary and Function in Cervical Cancer Patients Who Underwent Radical Hysterectomy Yoon A11, Lee YY, Park W, Huh SJ, Choi CH, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • Int J Clin Exp Pathol. 2015 May 1;8(5):5688-94. eCollection 2015. 2015 Analysis of clinical outcomes of patients with adenoid cystic carcinoma of Bartholin glands Yoon G11, Kim HS2, Lee YY3, Kim TJ3, Choi CH3, Song SY4, Kim BG3, Bae DS3, Lee JW3.
    View PubMed
  • Taiwan J Obstet Gynecol. 2015 Apr;54(2):150-4. doi: 10.1016/j.tjog.2014.05.005. 2015 Is laparoendoscopic single-site surgery (LESS) retroperitoneal hysterectomy feasible: Surgical outcomes of the initial 27 cases Kim TH11, Kim TJ2, Yoo HN1, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG1.
    View PubMed
  • J Gynecol Oncol. 2015 Jan;26(1):68-74. doi: 10.3802/jgo.2015.26.1.68. 2015 Asian Society of Gynecologic Oncology International Workshop 2014 Park JY11, Ngan HY2, Park W3, Cao Z4, Wu X5, Ju W6, Chung HH7, Chang SJ8, Park SY9, Ryu SY10, Kim JH11, Cho CH12, Lee KH13, Lee JW14, Kumarasamy S15, Kim JW7, Wilailak S16, Kim BG14, Kim DY1, Konishi I17, Lee JK18, Wang KL19, Nam JH20.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2015 Jan;184:38-42. doi: 10.1016/j.ejogrb.2014.10.001. Epub 2014 Oct 14. 2015 Borderline ovarian tumor in women aged >= 65 years: impact on recurrence and survival Song T11, Lee YY2, Choi CH2, Kim TJ2, Lee JW2, Bae DS2, Kim BG3.
    View PubMed
  • J Gynecol Oncol. 2015 Jan;26(1):62-7. doi: 10.3802/jgo.2015.26.1.62. 2015 Single-site robotic surgery in gynecologic cancer: a pilot study Yoo HN11, Kim TJ2, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG1.
    View PubMed
  • Radiology. 2014 Nov;273(2):462-71. doi: 10.1148/radiol.14132719. Epub 2014 Jul 1. 2014 Uterine Fibroids: Semiquantitative Perfusion MR Imaging Parameters Associated with the Intraprocedural and Immediate Postprocedural Treatment Efficiencies of MR Imaging-guided High-Intensity Focused Ultrasound Ablation Kim YS11, Kim BG, Rhim H, Bae DS, Lee JW, Kim TJ, Choi CH, Lee YY, Lim HK.
    View PubMed
  • Gynecol Oncol. 2014 Oct;135(1):108-17. doi: 10.1016/j.ygyno.2014.06.031. Epub 2014 Jul 9. 2014 Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma Park YA11, Choi CH1, Do IG2, Song SY2, Lee JK3, Cho YJ1, Choi JJ1, Jeon HK1, Ryu JY1, Lee YY1, Kim TJ1, Bae DS1, Lee JW4, Kim BG5.
    View PubMed
  • Int J Gynecol Cancer. 2014 Oct;24(8):1466-73. doi: 10.1097/IGC.0000000000000232. 2014 Robotic Versus Laparoscopic Radical Hysterectomy in Cervical Cancer Patients A Matched-Case Comparative Study Kim TH11, Choi CH, Choi JK, Yoon A, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Taiwan J Obstet Gynecol. 2014 Sep;53(3):343-7. doi: 10.1016/j.tjog.2013.10.041. 2014 Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings Kim HJ11, Choi CH2, Lee YY2, Kim TJ2, Lee JW2, Bae DS2, Kim BG3.
    View PubMed
  • Int J Gynecol Cancer. 2014 Sep;24(7):1299-305. doi: 10.1097/IGC.0000000000000197. 2014 Prognostic Factors Influencing Decisions About Surgical Treatment of Villoglandular Adenocarcinoma of the Uterine Cervix Kim HJ11, Sung JH, Lee E, Ahn S, Song SY, Choi CH, Kim TJ, Kim BG, Bae DS, Lee JW.
    View PubMed
  • Int J Gynecol Cancer. 2014 Sep;24(7):1206-14. doi: 10.1097/IGC.0000000000000216. 2014 Risk Factors for Progression to Invasive Carcinoma in Patients With Borderline Ovarian Tumors Song T11, Lee YY, Choi CH, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Am J Obstet Gynecol. 2014 Aug;211(2):168.e1-7. doi: 10.1016/j.ajog.2014.02.032. Epub 2014 Mar 4. 2014 Postoperative outcomes of MR-invisible stage IB1 cervical cancer Park JY11, Lee JW1, Park BK2, Lee YY1, Choi CH1, Kim TJ1, Bae DS1, Kim BG1, Park JJ3, Park SY3, Kim CK3.
    View PubMed
  • J Minim Invasive Gynecol. 2014 Jul-Aug;21(4):580-5. doi: 10.1016/j.jmig.2013.12.096. Epub 2013 Dec 31. 2014 Surgical Outcomes of a New Approach to Laparoscopic Myomectomy: Single-Port and Modified Suture Technique Choi CH11, Kim TH1, Kim SH1, Choi JK1, Park JY1, Yoon A1, Lee YY1, Kim TJ1, Lee JW1, Kim BG1, Bae DS2.
    View PubMed
  • J Cancer Res Clin Oncol. 2014 Jul;140(7):1179-88. doi: 10.1007/s00432-014-1658-7. Epub 2014 Mar 27. 2014 Meta-analysis of the effects of beta blocker on survival time in cancer patients Choi CH11, Song T, Kim TH, Choi JK, Park JY, Yoon A, Lee YY, Kim TJ, Bae DS, Lee JW, Kim BG.
    View PubMed
  • Support Care Cancer. 2014 May;22(5):1181-7. doi: 10.1007/s00520-013-2070-6. Epub 2013 Dec 12. 2014 Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin Choi CH11, Kim MK, Park JY, Yoon A, Kim HJ, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • J Laparoendosc Adv Surg Tech A. 2014 Apr;24(4):254-9. doi: 10.1089/lap.2013.0507. Epub 2014 Feb 25. 2014 Comparison of Laparoendoscopic Single-Site Hysterectomies: Laparoscopic Hysterectomy with Some Vaginal Component Versus Laparoscopically Assisted Vaginal Hysterectomy Kim TJ11, Song T, Choi CH, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:58-61. doi: 10.1016/j.ejogrb.2014.01.004. Epub 2014 Jan 17. 2014 Laparoendoscopic single-site (LESS) myomectomy: characteristics of the appropriate myoma Yoon A11, Kim TJ1, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG2.
    View PubMed
  • Clin Cancer Res. 2014 Feb 1;20(3):565-75. doi: 10.1158/1078-0432.CCR-13-1271. Epub 2013 Nov 6. 2014 Tumor Suppressive Effects of Bromodomain-Containing Protein 7 (BRD7) in Epithelial Ovarian Carcinoma Park YA11, Lee JW, Kim HS, Lee YY, Kim TJ, Choi CH, Choi JJ, Jeon HK, Cho YJ, Ryu JY, Kim BG, Bae DS.
    View PubMed
  • Int J Gynecol Cancer. 2014 Jan;24(1):107-12. doi: 10.1097/IGC.0000000000000015. 2014 Bone Metastasis in Primary Endometrial Carcinoma Features, Outcomes, and Predictors Yoon A11, Choi CH, Kim TH, Choi JK, Park JY, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Gynecol Oncol. 2014 Jan;132(1):70-5. doi: 10.1016/j.ygyno.2013.10.029. Epub 2013 Oct 31. 2014 Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: A multicenter review of 114 cases Yoon A11, Park JY2, Park JY1, Lee YY1, Kim TJ1, Choi CH1, Bae DS1, Kim BG1, Lee JW3, Nam JH4.
    View PubMed
  • Gynecol Oncol. 2013 Dec;131(3):650-4. doi: 10.1016/j.ygyno.2013.10.003. Epub 2013 Oct 18. 2013 Genetic profiling to predict recurrence of early cervical cancer Lee YY11, Kim TJ, Kim JY, Choi CH, Do IG, Song SY, Sohn I, Jung SH, Bae DS, Lee JW, Kim BG.
    View PubMed
  • Anticancer Res. 2013 Aug;33(8):3177-84. 2013 The Effect of Surgical Wound on Ovarian Carcinoma Growth in an Animal Model Lee JW11, Park YA, Cho YJ, Kang KH, Choi JJ, Lee YY, Kim TJ, Choi CH, Kim BG, Bae DS.
    View PubMed
  • Anticancer Res. 2013 Apr;33(4):1555-61. 2013 Clinical Significance of Galectin-7 in Epithelial Ovarian Cancer Kim HJ11, Jeon HK, Lee JK, Sung CO, Do IG, Choi CH, Kim TJ, Kim BG, Bae DS, Lee JW.
    View PubMed
  • J Gynecol Oncol. 2013 Apr;24(2):186-203. doi: 10.3802/jgo.2013.24.2.186. Epub 2013 Apr 5. 2013 Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition Lee JK11, Hong JH, Kang S, Kim DY, Kim BG, Kim SH, Kim YM, Kim JW, Kim JH, Kim TJ, Kim HJ, Kim HS, Ryu HS, Song JY, Ahn HS, Yoo CW, Yoon HK, Lee KH, Lee A, Lee Y, Lee IH, Lee JW, Lee TS, Lim MC, Chang SJ, Chung HH, Ju W, Joo HJ, Hur SY, Hong SR, Nam JH.
    View PubMed
  • J Minim Invasive Gynecol. 2013 Mar-Apr;20(2):166-71. doi: 10.1016/j.jmig.2012.10.008. Epub 2013 Jan 5. 2013 Management and Outcome of Rectal Injury During Gynecologic Laparoscopic Surgery Jo EJ11, Lee YY, Kim TJ, Choi CH, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Mol Pharm. 2013 Feb 4;10(2):763-73. doi: 10.1021/mp300344p. Epub 2013 Jan 14. 2013 Efficient siRNA Delivery into Tumor Cells by p19-YSA Fusion Protein Choi KM11, Park GL, Hwang KY, Lee JW, Ahn HJ.
    View PubMed
  • J Gynecol Oncol. 2013 Jan;24(1):96-7. doi: 10.3802/jgo.2013.24.1.96. Epub 2013 Jan 8. 2013 Pharmacokinetics and cytotoxic effect of selenium compounds in rodent cancer xenograft model for therapy experiment Reply 1,Hwang JY1.
    View PubMed
  • Hum Pathol. 2013 Jan;44(1):62-8. doi: 10.1016/j.humpath.2012.04.010. Epub 2012 Aug 30. 2013 Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer Kim HJ11, Do IG, Jeon HK, Cho YJ, Park YA, Choi JJ, Sung CO, Lee YY, Choi CH, Kim TJ, Kim BG, Lee JW, Bae DS.
    View PubMed
  • Int J Clin Oncol. 2012 Dec;17(6):590-7. doi: 10.1007/s10147-011-0329-9. Epub 2011 Oct 13. 2012 Ploidy and S-phase fraction are correlated with lymphovascular space invasion that is predictive of outcomes in endometrial cancer Song T11, Lee JW, Choi CH, Kim TJ, Bae DS, Sung CO, Song SY, Kim BG.
    View PubMed
  • Anticancer Res. 2012 Dec;32(12):5285-9. 2012 The Effect of High-intensity Focused Ultrasound in Combination with Cisplatin Using a Xenograft Model of Cervical Cancer Lee YY11, Cho YJ, Choi JJ, Choi CH, Kim TJ, Kim BG, Bae DS, Kim YS, Lee JW.
    View PubMed
  • Ann Surg Oncol. 2012 Nov;19(12):3839-48. doi: 10.1245/s10434-012-2406-3. Epub 2012 May 30. 2012 Comparison of Laparoscopic-Assisted Radical Vaginal Hysterectomy and Laparoscopic Radical Hysterectomy in the Treatment of Cervical Cancer Choi CH11, Lee JW, Lee YY, Kim HJ, Song T, Kim MK, Kim TJ, Kim BG, Bae DS.
    View PubMed
  • J Gynecol Oncol. 2012 Oct;23(4):226-34. doi: 10.3802/jgo.2012.23.4.226. Epub 2012 Sep 19. 2012 Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer Park JY11, Kim DY, Kim JH, Kim YM, Kim YT, Kim YS, Kim HJ, Lee JW, Kim BG, Bae DS, Huh SJ, Nam JH.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2012 Oct;164(2):180-4. doi: 10.1016/j.ejogrb.2012.05.029. Epub 2012 Sep 7. 2012 Dynamin 2 expression as a biomarker in grading of cervical intraepithelial neoplasia Lee YY11, Song SY, Do IG, Kim TJ, Kim BG, Lee JW, Bae DS.
    View PubMed
  • Eur J Cancer. 2012 Aug;48(12):1914-21. doi: 10.1016/j.ejca.2012.02.005. Epub 2012 Mar 2. 2012 High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion Kim HJ11, Jeon HK, Cho YJ, Park YA, Choi JJ, Do IG, Song SY, Lee YY, Choi CH, Kim TJ, Bae DS, Lee JW, Kim BG.
    View PubMed
  • J Gynecol Oncol. 2012 Jul;23(3):190-6. doi: 10.3802/jgo.2012.23.3.190. Epub 2012 Jul 2. 2012 The effects of selenium on tumor growth in epithelial ovarian carcinoma Park JS11, Ryu JY, Jeon HK, Cho YJ, Park YA, Choi JJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • J Mol Cell Biol. 2012 Jun;4(3):164-73. doi: 10.1093/jmcb/mjs018. Epub 2012 Apr 24. 2012 Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer Choi JW11, Lee JW, Kim JK, Jeon HK, Choi JJ, Kim DG, Kim BG, Nam DH, Kim HJ, Yun SH, Kim S.
    View PubMed
  • Gynecol Oncol. 2012 May;125(2):427-32. doi: 10.1016/j.ygyno.2012.01.030. Epub 2012 Jan 28. 2012 Expression of 67-kDa laminin receptor was associated with tumor progression and poor prognosis in epithelial ovarian cancer Song T11, Choi CH, Cho YJ, Sung CO, Song SY, Kim TJ, Bae DS, Lee JW, Kim BG.
    View PubMed
  • Gynecol Oncol. 2012 Jan;124(1):125-33. doi: 10.1016/j.ygyno.2011.09.026. Epub 2011 Oct 19. 2012 The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma Park YA11, Lee JW, Choi JJ, Jeon HK, Cho Y, Choi C, Kim TJ, Lee NW, Kim BG, Bae DS.
    View PubMed
  • J Gynecol Oncol. 2011 Dec;22(4):292-4. doi: 10.3802/jgo.2011.22.4.292. Epub 2011 Dec 5. 2011 Long-term recurrence-free survival in a patient with stage IVB uterine carcinosarcoma Yoon G11, Kim YS, Kim BG, Bae DS, Lee JW.
    View PubMed
  • Int J Clin Oncol. 2011 Oct;16(5):601-4. doi: 10.1007/s10147-010-0174-2. Epub 2011 Jan 6. 2011 Myxoid malignant fibrous histiocytoma of the ovary: a case report Choi SY11, Kim TH, Park HS, Sung CO, Lee JW, Song SY, Kim BG, Bae DS.
    View PubMed
  • Int J Clin Oncol. 2011 Aug;16(4):352-8. doi: 10.1007/s10147-011-0190-x. Epub 2011 Feb 16. 2011 Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma Kim MK11, Sung CO, Do IG, Jeon HK, Song TJ, Park HS, Lee YY, Kim BG, Lee JW, Bae DS.
    View PubMed
  • Gynecol Oncol. 2011 Jul;122(1):79-82. doi: 10.1016/j.ygyno.2011.03.017. Epub 2011 Apr 13. 2011 Prognostic significance of DNA ploidy in stage I endometrial cancer Song T11, Lee JW, Kim HJ, Kim MK, Choi CH, Kim TJ, Bae DS, Kim BG.
    View PubMed
  • Neoplasia. 2011 Apr;13(4):309-19. 2011 Targeted Delivery of Small Interfering RNA Using Reconstituted High-Density Lipoprotein Nanoparticles Shahzad MM11, Mangala LS, Han HD, Lu C, Bottsford-Miller J, Nishimura M, Mora EM, Lee JW, Stone RL, Pecot CV, Thanapprapasr D, Roh JW, Gaur P, Nair MP, Park YY, Sabnis N, Deavers MT, Lee JS, Ellis LM, Lopez-Berestein G, McConathy WJ, Prokai L, Lacko AG, Sood AK.
    View PubMed
  • Eur J Cancer. 2011 Apr;47(6):918-25. doi: 10.1016/j.ejca.2010.11.007. Epub 2010 Dec 4. 2011 High claudin-7 expression is associated with a poor response to platinum-based chemotherapy in epithelial ovarian carcinoma Kim CJ11, Lee JW, Choi JJ, Choi HY, Park YA, Jeon HK, Sung CO, Song SY, Lee YY, Choi CH, Kim TJ, Lee JH, Kim BG, Bae DS.
    View PubMed
  • Clin Cancer Res. 2011 Apr 1;17(7):1713-21. doi: 10.1158/1078-0432.CCR-10-2081. Epub 2011 Feb 7. 2011 Functional Roles of Src and Fgr in Ovarian Carcinoma Kim HS11, Han HD, Armaiz-Pena GN, Stone RL, Nam EJ, Lee JW, Shahzad MM, Nick AM, Lee SJ, Roh JW, Nishimura M, Mangala LS, Bottsford-Miller J, Gallick GE, Lopez-Berestein G, Sood AK.
    View PubMed
  • Gynecol Oncol. 2011 Jan;120(1):56-62. doi: 10.1016/j.ygyno.2010.09.022. Epub 2010 Oct 28. 2011 The expression of the miRNA-200 family in endometrial endometrioid carcinoma Lee JW11, Park YA, Choi JJ, Lee YY, Kim CJ, Choi C, Kim TJ, Lee NW, Kim BG, Bae DS.
    View PubMed
  • J Biol Chem. 2010 Nov 12;285(46):35462-70. doi: 10.1074/jbc.M110.109579. Epub 2010 Sep 8. 2010 Stress Effects on FosB- and Interleukin-8 (IL8)-driven Ovarian Cancer Growth and Metastasis Shahzad MM11, Arevalo JM, Armaiz-Pena GN, Lu C, Stone RL, Moreno-Smith M, Nishimura M, Lee JW, Jennings NB, Bottsford-Miller J, Vivas-Mejia P, Lutgendorf SK, Lopez-Berestein G, Bar-Eli M, Cole SW, Sood AK.
    View PubMed
  • Gynecol Oncol. 2010 Oct;119(1):87-91. doi: 10.1016/j.ygyno.2010.05.030. Epub 2010 Jun 26. 2010 Sequence-dependent hematologic side effects of topotecan and cisplatin in persistent or recurrent cervical cancer Lee YY11, Lee JW, Park HS, Song TJ, Kim MK, Choi CH, Kim TJ, Lee JH, Bae DS, Kim BG.
    View PubMed
  • Cancer Biol Ther. 2010 Aug 15;10(4):329-35. Epub 2010 Aug 7. 2010 Low dynamin 2 expression is associated with tumor invasion and metastasis in invasive squamous cell carcinoma of cervix Lee YY11, Do IG, Park YA, Choi JJ, Song SY, Kim CJ, Kim MK, Song TJ, Park HS, Choi CH, Kim TJ, Kim BG, Lee JW, Bae DS.
    View PubMed
  • Clin Cancer Res. 2010 Aug 1;16(15):3910-22. doi: 10.1158/1078-0432.CCR-10-0005. Epub 2010 Jun 10. 2010 Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles Han HD11, Mangala LS, Lee JW, Shahzad MM, Kim HS, Shen D, Nam EJ, Mora EM, Stone RL, Lu C, Lee SJ, Roh JW, Nick AM, Lopez-Berestein G, Sood AK.
    View PubMed
  • Cancer Cell. 2010 Aug 9;18(2):185-97. doi: 10.1016/j.ccr.2010.06.016. 2010 Regulation of Tumor Angiogenesis by EZH2 Lu C11, Han HD, Mangala LS, Ali-Fehmi R, Newton CS, Ozbun L, Armaiz-Pena GN, Hu W, Stone RL, Munkarah A, Ravoori MK, Shahzad MM, Lee JW, Mora E, Langley RR, Carroll AR, Matsuo K, Spannuth WA, Schmandt R, Jennings NB, Goodman BW, Jaffe RB, Nick AM, Kim HS, Guven EO, Chen YH, Li LY, Hsu MC, Coleman RL, Calin GA, Denkbas EB, Lim JY, Lee JS, Kundra V, Birrer MJ, Hung MC, Lopez-Berestein G, Sood AK.
    View PubMed
  • Clin Cancer Res. 2010 May 1;16(9):2562-70. doi: 10.1158/1078-0432.CCR-10-0017. Epub 2010 Apr 13. 2010 EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma Lee JW11, Stone RL, Lee SJ, Nam EJ, Roh JW, Nick AM, Han HD, Shahzad MM, Kim HS, Mangala LS, Jennings NB, Mao S, Gooya J, Jackson D, Coleman RL, Sood AK.
    View PubMed
  • J Natl Cancer Inst. 2009 Sep 2;101(17):1193-205. doi: 10.1093/jnci/djp231. Epub 2009 Jul 29. 2009 EphA2 Immunoconjugate as Molecularly Targeted Chemotherapy for Ovarian Carcinoma Lee JW11, Han HD, Shahzad MM, Kim SW, Mangala LS, Nick AM, Lu C, Langley RR, Schmandt R, Kim HS, Mao S, Gooya J, Fazenbaker C, Jackson D, Tice DA, Landen CN, Coleman RL, Sood AK.
    View PubMed
  • Clin Cancer Res. 2009 Jun 1;15(11):3770-80. doi: 10.1158/1078-0432.CCR-08-2306. Epub 2009 May 26. 2009 Therapeutic Targeting of ATP7B in Ovarian Carcinoma Mangala LS11, Zuzel V, Schmandt R, Leshane ES, Halder JB, Armaiz-Pena GN, Spannuth WA, Tanaka T, Shahzad MM, Lin YG, Nick AM, Danes CG, Lee JW, Jennings NB, Vivas-Mejia PE, Wolf JK, Coleman RL, Siddik ZH, Lopez-Berestein G, Lutsenko S, Sood AK.
    View PubMed
  • Clin Cancer Res. 2009 Apr 15;15(8):2695-702. doi: 10.1158/1078-0432.CCR-08-2966. Epub 2009 Apr 7. 2009 Surgical Stress Promotes Tumor Growth in Ovarian Carcinoma Lee JW11, Shahzad MM, Lin YG, Armaiz-Pena G, Mangala LS, Han HD, Kim HS, Nam EJ, Jennings NB, Halder J, Nick AM, Stone RL, Lu C, Lutgendorf SK, Cole SW, Lokshin AE, Sood AK.
    View PubMed
  • Clin Cancer Res. 2008 May 1;14(9):2535-42. doi: 10.1158/1078-0432.CCR-07-1231. 2008 Altered MicroRNA expression in cervical carcinomas Lee JW11, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, Bae DS.
    View PubMed
  • Int J Gynecol Cancer. 2008 Mar-Apr;18(2):300-5. Epub 2007 Jun 22. 2008 Increased expression of Toll-like receptor 5 during progression of cervical neoplasia Kim WY11, Lee JW, Choi JJ, Choi CH, Kim TJ, Kim BG, Song SY, Bae DS.
    View PubMed
  • Mol Carcinog. 2007 Nov;46(11):941-7. 2007 Increased toll-like receptor 9 expression in cervical neoplasia Lee JW11, Choi JJ, Seo ES, Kim MJ, Kim WY, Choi CH, Kim TJ, Kim BG, Song SY, Bae DS.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):817-22. Epub 2007 Mar 26. 2007 Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: Preliminary results Choi CH11, Lee JW, Kim TJ, Kim WY, Nam HR, Kim BG, Huh SJ, Lee JH, Bae DS.
    View PubMed
  • J Cancer Res Clin Oncol. 2006 Apr;132(4):241-7. Epub 2005 Dec 21. 2006 Decreased galectin-3 expression during the progression of cervical neoplasia Lee JW11, Song SY, Choi JJ, Choi CH, Kim TJ, Kim J, Lee JH, Kim BG, Bae DS.
    View PubMed
  • Hum Pathol. 2005 Nov;36(11):1197-203. Epub 2005 Oct 7. 2005 eIF-4E expression is associated with histopathologic grades in cervical neoplasia Lee JW11, Choi JJ, Lee KM, Choi CH, Kim TJ, Lee JH, Kim BG, Ahn G, Song SY, Bae DS.
    View PubMed
  • Clin Oncol (R Coll Radiol). 2005 Sep;17(6):412-7. 2005 Preliminary results of consolidation chemotherapy following concurrent chemoradiation after radical surgery in high-risk early-stage carcinoma of the uterine cervix Lee JW11, Kim BG, Lee SJ, Lee SH, Park CS, Lee JH, Huh SJ, Bae DS.
    View PubMed
  • J Korean Med Sci. 2005 Jun;20(3):468-72. 2005 Selected adnexal cystic masses in postmenopausal women can be safely managed by lapcroscopy Lee JW11, Kim CJ, Lee JE, Lee SJ, Kim BG, Lee JH, Bae DS, Park CS.
    View PubMed
  • Hum Pathol. 2005 Jun;36(6):626-33. 2005 Increased expression of matriptase is associated with histopathologic grades of cervical neoplasia Lee JW11, Yong Song S, Choi JJ, Lee SJ, Kim BG, Park CS, Lee JH, Lin CY, Dickson RB, Bae DS.
    View PubMed
  • Gynecol Oncol. 2005 Apr;97(1):53-9. 2005 Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia Lee JW11, Lee SJ, Seo J, Song SY, Ahn G, Park CS, Lee JH, Kim BG, Bae DS.
    View PubMed